Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cue Biopharma Inc (NQ: CUE )

1.030 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,611
Open 1.030
Bid (Size) 1.010 (1)
Ask (Size) 1.050 (1)
Prev. Close 1.030
Today's Range 1.030 - 1.030
52wk Range 0.4500 - 3.249
Shares Outstanding 44,959,548
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Cue Biopharma Reports Third Quarter 2024 Financial Results and Recent Business Highlights
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Announces Strategic Organizational Transition
From Cue Biopharma, Inc.
Via GlobeNewswire

Performance

YTD
-62.95%
-62.95%
1 Month
-35.62%
-35.62%
3 Month
+26.36%
+26.36%
6 Month
-40.80%
-40.80%
1 Year
-56.90%
-56.90%

More News

Read More
Cue Biopharma to Participate in Fireside Chat at the Stifel 2024 Healthcare Conference
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Presents Positive Updated Data from its Phase 1 Trials of CUE-101 and CUE-102 in Head and Neck Cancer and WT1 Positive Cancers at the SITC 39th Annual Meeting
From Cue Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting
From Cue Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Announces Proposed Public Offering
From Cue Biopharma, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Cue Biopharma Announces Proposed Public Offering
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
From Cue Biopharma, Inc.
Via GlobeNewswire
CUE Stock Earnings: Cue Biopharma Beats EPS, Beats Revenue for Q2 2024
Via InvestorPlace
Cue Biopharma to Host Business Update Call and Webcast
From Cue Biopharma, Inc.
Via GlobeNewswire
Cue Biopharma Announces Strategic Prioritization of Autoimmune Programs Enabling Optimization of Workforce and Reduction of Capital Requirements
From Cue Biopharma, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.